# Case report: Primary pulmonary rhabdomyosarcoma exhibiting epithelial morphology and unusual immunophenotype – A significant diagnostic pitfall

**Authors:** Zonghua Wen, Wenting Li, Yao Liu, Hongyun Chen, Xuxu Wen, Jun Wang, Yungang Lv, Ruodai Wu, Yuhong Meng

PMC · DOI: 10.1016/j.rmcr.2026.102389 · Respiratory Medicine Case Reports · 2026-02-18

## TL;DR

A rare case of lung rhabdomyosarcoma was misdiagnosed due to its unusual appearance and protein markers, highlighting the challenges in identifying this cancer.

## Contribution

This is the first reported case of epithelioid rhabdomyosarcoma with strong TTF-1 expression using two antibody clones.

## Key findings

- The tumor showed epithelioid morphology without typical rhabdomyoblastic features.
- Tumor cells were positive for skeletal muscle markers and TTF-1, mimicking neuroendocrine carcinoma.
- The case highlights the diagnostic difficulty of PPRMS due to its atypical immunophenotype.

## Abstract

Primary pulmonary rhabdomyosarcoma(PPRMS) is an extremely rare neoplasm.Herin,we report a case of a 60-year-old male who presented with a one-week history of progressive chest tightness and non-radiating chest pain. Contrast-enhanced thoracic computed tomography (CT) demonstrated a large,11cm mass in the right inferior lung lobe. Intraoperative frozen-section analysis initially misclassified the lesion as a poorly differentiated carcinoma. The patient subsequently underwent thoracoscopic right lower lobectomy with systematic mediastinal lymph node dissection. Histological examination demonstrated sheets of uniformly sized epithelioid cells arranged in an organoid nesting growth pattern, with areas of geographic necrosis and no definitive morphological features indicative of rhabdomyoblastic differentiation. Immunohistochemical(IHC) staining confirmed diffuse positivity for skeletal muscle lineage markers(desmin, myogenin, MyoD1) in the tumor cells, thereby establishing a definitive diagnosis of rhabdomyosarcoma. Notably, this case showed diffuse expression of thyroid transcription factor 1 (TTF-1) using both the 8G7G3 and SPT24 clones, alongside immunoreactivity for neuroendocrine markers(CD56, PGP9.5) and focal expression of epithelial markers(AE1/AE3, CAM5.2), This immunophenotypic profile may mimic that of poorly differentiated neuroendocrine carcinoma, contributing to diagnostic confusion. The constellation of these unusual histological and immunophenotypic features presents a substantial diagnostic challenge. We herein elaborate on these findings to enhance clinical awareness and facilitate accurate diagnosis in future cases. To the best of our knowledge, To the best of our knowledge, this is the first reported case of epithelioid rhabdomyosarcoma demonstrating diffuse and strong nuclear TTF-1 immunoreactivity across two distinct antibody clones.

## Linked entities

- **Proteins:** LOC101066771 (desmin-like), myog.S (myogenin S homeolog), MYOD1 (myogenic differentiation 1), TTF1 (transcription termination factor 1), NCAM1 (neural cell adhesion molecule 1), UCHL1 (ubiquitin C-terminal hydrolase L1)
- **Diseases:** rhabdomyosarcoma (MONDO:0005212), neuroendocrine carcinoma (MONDO:0002120)

## Full-text entities

- **Genes:** INSM1 (INSM transcriptional repressor 1) [NCBI Gene 3642] {aka IA-1, IA1}, NKX2-1 (NK2 homeobox 1) [NCBI Gene 7080] {aka BCH, BHC, NK-2, NKX2.1, NKX2A, NMTC1}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, IL9 (interleukin 9) [NCBI Gene 3578] {aka HP40, IL-9, P40}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, UCHL1 (ubiquitin C-terminal hydrolase L1) [NCBI Gene 7345] {aka HEL-117, HEL-S-53, NDGOA, PARK5, PGP 9.5, PGP9.5}, TTF1 (transcription termination factor 1) [NCBI Gene 7270] {aka TTF-1, TTF-I}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, PAX7 (paired box 7) [NCBI Gene 5081] {aka CMYO19, CMYP19, HUP1, MYOSCO, PAX7B, RMS2}, MYOG (myogenin) [NCBI Gene 4656] {aka MYF4, bHLHc3, myf-4}, NAPSA (napsin A aspartic peptidase) [NCBI Gene 9476] {aka KAP, Kdap, NAP1, NAPA, NR1H2-AS1, SNAPA}, MYOD1 (myogenic differentiation 1) [NCBI Gene 4654] {aka CMYO17, CMYP17, MYF3, MYOD, MYODRIF, PUM}, NUTM1 (NUT midline carcinoma family member 1) [NCBI Gene 256646] {aka C15orf55, FAM22H, NUT}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, SALL4 (spalt like transcription factor 4) [NCBI Gene 57167] {aka DRRS, HSAL4, IVIC, ZNF797}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CD34 (CD34 molecule) [NCBI Gene 947], SLC4A1 (solute carrier family 4 member 1 (Diego blood group)) [NCBI Gene 6521] {aka AE1, BND3, CD233, CHC, DI, EMPB3}, ERG (ETS transcription factor ERG) [NCBI Gene 2078] {aka LMPHM14, erg-3, p55}, SSTR2 (somatostatin receptor 2) [NCBI Gene 6752] {aka SST2}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, FLI1 (Fli-1 proto-oncogene, ETS transcription factor) [NCBI Gene 2313] {aka BDPLT21, EWSR2, FLI-1, SIC-1}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, SMARCB1 (SWI/SNF related BAF chromatin remodeling complex subunit B1) [NCBI Gene 6598] {aka BAF47, CSS3, INI-1, INI1, MRD15, PPP1R144}, KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}
- **Diseases:** necrosis (MESH:D009336), diffuse large B-cell lymphomas (MESH:D016403), poorly differentiated carcinomas (MESH:D020522), primary pulmonary epithelioid (MESH:D006976), ERMS (MESH:D018233), mesothelioma (MESH:D008654), neuroendocrine carcinoma (MESH:D018278), nephroblastomas (MESH:D009396), central nervous system tumors (MESH:D016543), epithelial neoplasms (MESH:D009375), ARMS (MESH:D018232), thyroid carcinomas (MESH:D013964), death (MESH:D003643), neuroendocrine tumors (MESH:D018358), embryonal tumors (MESH:D009373), epithelioid (MESH:D012509), Primary pulmonary rhabdomyosarcoma (MESH:C537883), LCNEC (MESH:D018287), PRMS (MESH:D012208), sclerosing (MESH:D012598), mesenchymal tumors (MESH:C535700), chest pain (MESH:D002637), Lung Window (MESH:D008171), Tumor (MESH:D009369), pulmonary adenocarcinomas (MESH:D000230), peripheral T-cell lymphomas (MESH:D016411), epithelial tumors (MESH:D002277)
- **Chemicals:** paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955165/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12955165/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12955165/full.md

---
Source: https://tomesphere.com/paper/PMC12955165